Literature DB >> 33478954

Correspondence on 'Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients'.

Tanaz A Kermani1.   

Abstract

Entities:  

Keywords:  COVID-19; biological therapy; systemic vasculitis

Year:  2021        PMID： 33478954     DOI： 10.1136/annrheumdis-2021-219879

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  Scleroderma renal crisis following Covid-19 infection.

Authors:  Doron Rimar; Itzhak Rosner; Gleb Slobodin
Journal:  J Scleroderma Relat Disord       Date:  2021-05-28

Review 2.  BNT162b2 vaccine considerations for immunocompromised individuals: A global perspective.

Authors:  Hafsa Nazir Jatoi; Samina Abbas; Muhammad Saif Abbasi; Misha Asif Tauni; Shamas Ghazanfar; Mohammad Daniyal Zafar Malick; Muhammad Faiq Umar; Muhammad Junaid Tahir; Muhammad Sohaib Asghar; Ali Ahmed
Journal:  Ann Med Surg (Lond)       Date:  2022-05-17

3.  Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study.

Authors:  Dalifer Freites Nuñez; Leticia Leon; Alfredo Madrid Garcia; Jose Ignacio Colomer Arce; Arkaitz Mucientes; Benjamin Gutierrez-Fernandez; Luis Rodriguez; Inés Pérez San Cristóbal; Paula Álvarez; Cristina Martinez Prada; Lydia Abasolo
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-04-29       Impact factor: 3.625
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.